touchPANEL DISCUSSION for touchONCOLOGY
Listen to three experts discuss the treatment of recurrent/metastatic head and neck squamous cell carcinoma (HNSCC), including the latest clinical trial data and how it informs clinical practice, and how patient priorities can be established and incorporated into the care plan.
The experts
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent grant from the healthcare business of Merck KGaA, Darmstadt. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: https://touchoncology.com/cme/treatment-provision-recurrent-metastatic-hnscc/
